Abu Dhabi: Abu Dhabi Health Services Company, (SEHA), the UAE’s largest public healthcare network, hosted France’s Ambassador to the UAE, His Excellency Xavier Chatel to showcase the success of the third phase of the COVID-19 vaccine clinical trials.

French Ambassador Chatel was welcomed by Dr. Marwan Al Kaabi, Acting Group Chief Operations Officer, SEHA, Dr. Shamma Khalifa Al Mazrouei, Group Chief Operations Officer, and Dr. Nawal Ahmed Mohamed Al-Kaabi, Chief Medical Officer at Sheikh Khalifa Medical City, the UAE’s  Principal Investigator for Phase III Trials COVID-19 Vaccine, and Chairperson of the National COVID-19 Clinical Management Committee. He was accompanied by Sabine Sciortino, First Counsellor, Anne Douaire-Banny, Deputy Cultural Counsellor, Hanan El Chami, Economic Attachée, and Célia Darakdjian, Press Attachée. The delegation received a briefing on the processes followed in conducting the third phase of the clinical trials for the COVID-19 vaccine in the UAE, and its safe and effective distribution.

As part of the visit, the French Ambassador and delegation toured SEHA’s specialized center for conducting the clinical trials at Abu Dhabi Exhibition Center (ADNEC), which is managed by the network’s expert medical practitioners. Developed by Sinopharm CNBG and G42 Healthcare, a subsidiary of G42 Group, the inactive vaccine’s clinical trials are conducted as a collaboration between the Department of Health - Abu Dhabi and SEHA. The trials are aligned with the vision and commitment of the UAE’s leadership to effectively manage the pandemic and contribute to the global healthcare sector.

Dr. Nawal Ahmed Mohamed Al-Kaabi, Chief Medical Officer at Sheikh Khalifa Medical City, the UAE’s  Principal Investigator for Phase III Trials COVID-19 Vaccine, and Chairperson of the National COVID-19 Clinical Management Committee said: “We are proud of the progress made in delivering a COVID-19 vaccine, which is eagerly awaited by the global community. During Ambassador’s Chatel’s visit, we discussed the strides made in administering the vaccine to frontline healthcare professionals. We are grateful to all our partners and the entire UAE community for their collaboration and role in advancing our ambitions towards fighting this global pandemic.”

Ambassador Xavier Chatel declared : “I want to warmly thank Seha for welcoming me and my team today. Dr. Nawal Ahmed Mohamed Al-Kaabi gave us very useful insights about the COVID-19 vaccination process in the UAE and its challenges. This issue is of great interest to my fellow citizens living in the UAE. I learned a lot  during this visit, and I am sure it will be also interesting for my authorities, as they are also preparing the future roll-out of vaccines.”

The clinical trials are part of a global effort to combat COVID-19 and are being overseen by the World Health Organization (WHO) and the UAE’s Ministry of Health and Prevention. The trials are aligned with the UAE government’s prominent role in international efforts to find a solution to this century’s greatest health challenge .

-Ends-

About SEHA:

The Abu Dhabi Health Services Company PJSC–SEHA – is an independent, public joint stock company created to develop the curative activities of the public healthcare system in Abu Dhabi. The company owns and operates all the public hospitals and clinics of the Emirate of Abu Dhabi.

SEHA is part of ADQ, one of the region’s largest holding companies with a broad portfolio of major enterprises spanning key sectors of Abu Dhabi’s diversified economy.

SEHA is committed to continuous improvement of customer care to recognized international standards and providing the community with world-class healthcare. SEHA operates 13 hospitals with 3,385 beds, 70 ambulatory care, family care and urgent care centers and 2 blood banks. Its facilities accommodate 11,7162 inpatients annually and conduct 43,262 surgeries, as well as treating more than five million outpatients. SEHA is one of the largest integrated healthcare providers in the Middle East with more than 18,000 doctors, nurses, ancillary care, and administrative personnel. Learn more at www.seha.ae 

Send us your press releases to pressrelease.zawya@refinitiv.com

© Press Release 2020

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.